Literature DB >> 8942653

Cooperative action of Hsp70, Hsp90, and DnaJ proteins in protein renaturation.

R J Schumacher1, W J Hansen, B C Freeman, E Alnemri, G Litwack, D O Toft.   

Abstract

The proteins required for the repair of damaged proteins in the eukaryotic cytoplasm remain largely uncharacterized. The renaturation of thermally denatured firefly luciferase readily occurs in rabbit reticulocyte lysate by an ATP-dependent process. Earlier studies had shown that this chaperoning activity could be reconstituted, in part, using purified preparations of hsp70 and hsp90. We have extended the description of this system by clarifying the importance of hsp70 and hsp90 and have tested for additional factors that enhance renaturation. Using mutant hsp70 proteins, we have shown that hsp70 is required for luciferase renaturation. We have also found that hsp70 and hsp90 preparations purified by common procedures were contaminated with low levels of DnaJ proteins that are essential for the renaturing activity. When hsp70 and hsp90 preparations free of DnaJ proteins are used, the system must be supplemented with a DnaJ protein to obtain renaturation activity. The yeast DnaJ protein, YDJ-1, was found to be very effective for this purpose. Although significant renaturation can occur with only hsp70 and DnaJ proteins, hsp90 also contributes to the renaturation process, both in the complex environment of reticulocyte lysate and in a purified system. However, using highly purified hsp90 and geldanamycin, a specific inhibitor of hsp90 function, we have determined that hsp90 is not an essential component of the renaturation system. The contribution of hsp90 to renaturation is only partially blocked by geldanamycin, suggesting that this protein may influence activity in more than one way. This study indicates that hsp70, hsp90, and DnaJ proteins function cooperatively to renature damaged proteins in the eukaryotic cytoplasm and provides a framework by which additional components can be identified and individual chaperone contributions can be investigated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942653     DOI: 10.1021/bi961825h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  A small heat shock protein cooperates with heat shock protein 70 systems to reactivate a heat-denatured protein.

Authors:  G J Lee; E Vierling
Journal:  Plant Physiol       Date:  2000-01       Impact factor: 8.340

2.  Functional requirement of p23 and Hsp90 in telomerase complexes.

Authors:  S E Holt; D L Aisner; J Baur; V M Tesmer; M Dy; M Ouellette; J B Trager; G B Morin; D O Toft; J W Shay; W E Wright; M A White
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

3.  In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.

Authors:  Jianming Hu; David Toft; Dana Anselmo; Xingtai Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 4.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

5.  Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.

Authors:  Xingtai Wang; Xiaofeng Qian; Hwai-Chen Guo; Jianming Hu
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  The substrate binding domain of DnaK facilitates slow protein refolding.

Authors:  Naoki Tanaka; Shota Nakao; Hiromasa Wadai; Shoichi Ikeda; Jean Chatellier; Shigeru Kunugi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

7.  Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration.

Authors:  J Lille Tidwell; Lucien J Houenou; Michael Tytell
Journal:  Cell Stress Chaperones       Date:  2004-03       Impact factor: 3.667

Review 8.  Not all J domains are created equal: implications for the specificity of Hsp40-Hsp70 interactions.

Authors:  Fritha Hennessy; William S Nicoll; Richard Zimmermann; Michael E Cheetham; Gregory L Blatch
Journal:  Protein Sci       Date:  2005-07       Impact factor: 6.725

9.  High-throughput assay for the identification of Hsp90 inhibitors based on Hsp90-dependent refolding of firefly luciferase.

Authors:  Lakshmi Galam; M Kyle Hadden; Zeqiang Ma; Qi-Zhuang Ye; Bo-Geon Yun; Brian S J Blagg; Robert L Matts
Journal:  Bioorg Med Chem       Date:  2007-01-04       Impact factor: 3.641

10.  Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases.

Authors:  Ruth A Bodner; Tiago Fleming Outeiro; Stephen Altmann; Michele M Maxwell; Stephanie H Cho; Bradley T Hyman; Pamela J McLean; Anne B Young; David E Housman; Aleksey G Kazantsev
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.